This report contains market size and forecasts of Regorafenib in global, including the following market information:
Global Regorafenib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Regorafenib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Regorafenib companies in 2021 (%)
The global Regorafenib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bottled Packaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Regorafenib include Bayer Pharmaceuticals, Beacon Pharmaceuticals and Drug International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Regorafenib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Regorafenib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Regorafenib Market Segment Percentages, by Type, 2021 (%)
Bottled Packaging
Film Coated Packaging
Global Regorafenib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Regorafenib Market Segment Percentages, by Application, 2021 (%)
Metastatic Colorectal Cancer
Advanced Gastrointestinal Stromal Tumours
Advanced Hepatocellular Carcinoma
Other
Global Regorafenib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Regorafenib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Regorafenib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Regorafenib revenues share in global market, 2021 (%)
Key companies Regorafenib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Regorafenib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Pharmaceuticals
Beacon Pharmaceuticals
Drug International